Please login to the form below

Not currently logged in

Loxo Oncology

This page shows the latest Loxo Oncology news and features for those working in and with pharma, biotech and healthcare.

Lilly’s RET inhibitor Retevmo shows early promise in new cancer types

Lilly’s RET inhibitor Retevmo shows early promise in new cancer types

We are excited to broaden the body of evidence for Retevmo in RET fusion-positive cancers beyond lung and thyroid tumours," said David Hyman, chief medical officer, oncology at Lilly. ... The pharma giant picked up the oral RET inhibitor after acquiring

Latest news

More from news
Approximately 2 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Merck/MSD looks to have gained a dominant position in checkpoint inhibitor immuno-oncology (IO) with Keytruda – but there remains room for growth in the market via new IO agents. ... This is the first US product approval for Loxo Oncology and its

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Following after the first generation of mainly antibody-based immuno-oncology drugs are a host of small-molecule drugs. ... also extending to targeted cancer drugs, with Loxo Oncology and Bayer’s larotrectinib filed for TRK gene fusion tumours and due

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    485. Array BioPharma / Loxo Oncology. Multi-year licence and collaboration. Drug candidate (preclinical) discovery of small molecule drugs for oncology targets. ... 208. Talon Therapeutics / Spectrum Pharmaceuticals. Acquisition. Haemato-oncology

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....